Company profilePharmaceutical#430 of 1,318 in Pakistan1 DRAP alert

SUNSHINE PHARMACEUTICALS

Pharmaceutical company · 37 brands · 36 molecules

37 registered products 28 pharmaceutical brands 36 distinct molecules 1 DRAP alert

Company overview

37
registered products
28
pharmaceutical brands
36
distinct molecules
0
therapeutic classes
1
DRAP alerts

SUNSHINE PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 37 product registrations across 36 distinct molecules. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SUNSHINE

18 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

18
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202618

Top molecules by brand count

Amlodipine4 brands
Paracetamol4 brands
Levofloxacin3 brands
Allopurinol2 brands
Ibuprofen2 brands
Metformin2 brands
Amlodipine ...... 5 Mg2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official41 products · Rs 129.26 – Rs 980.18
Median across source: Rs 397.01

Regulatory record

1 alert in the DRAP feed we track.

RECALL ALERT -TABLET AMLOshine (all strengths & batches) – Sunshine Pharmaceuticals
2025-09-26

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MEGA PHARMACEUTICALS (PVT) LTD holds 38 molecules not in this portfolio
AllopurinolAscorbic AcidAspirinAtenololAzithromycinBisoprolol
STANDPHARM PAKISTAN (PVT) LTD. holds 66 molecules not in this portfolio
AlprazolamAmikacinAmoxicillinAmpicillinAscorbic AcidAspirin
MEDIATE PHARMACEUTICALS (PVT) LTD holds 102 molecules not in this portfolio
AcyclovirAlendronateAmoxicillinAmpicillinAmpicillin BaseAnastrozole

Get the full profile for SUNSHINE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.